An interventional study of Hybrid Telerehabilitation in Anterior Knee Pain, sponsored by Farraj Miguel. Recruiting at 2 sites in 2 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-30.
Sponsored by Farraj Miguel · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 150 studies in Pain with a site in Belgium — 24 open to participants now, 26 under way, none of them phase 3. Pain · Belgium.
Among the 150 studies in Pain with a site in Belgium, this one is the 91st largest by planned enrollment of the 115 interventional ones that give a count, is one of 6 that started in 2026, is one of 63 with no phase, reaches primary completion later than 21 of the 25 other live ones, and was the 150th registered.
10,060 studies on the registry are indexed under Pain; 1,651 are open to participants now.
Browse Pain studies →24 of the 150 studies in Pain with a site in Belgium are open now. Recruiting first, the newest first:
Erasme University Hospital · Sites in Belgium
Ages 18+
Jessa Hospital · Sites in Belgium
Ages 18+
Vrije Universiteit Brussel · Sites in Belgium
Ages 18–70 · Healthy volunteers
University Hospital, Gasthuisberg · Sites in Belgium
Ages 18+
Vrije Universiteit Brussel · Sites in Belgium
Ages 18–60 · Healthy volunteers
A study can be open while its sites in Belgium have not opened yet or have stopped. Only those recruiting at a site in Belgium →
Of the 929 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 222 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
150 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 10 · Phase 2 8 · Phase 3 24 · Phase 4 13
First in 2003; this study’s year is marked. 6 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 30 is below the median of 66 across 8,497 interventional studies indexed under Pain.
Median enrollment 64 across the 115 interventional studies, 108 across the 34 observational. Of the 113 that completed or were terminated, 22 (19%) have results posted.
This tab as a report to print or save as PDF → With an account.
44 of 150 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Farraj Miguel as lead sponsor.
Farraj Miguel has 1 study filed under Pain — fewer than ten, so there is no comparison to draw.
9 of the studies in Pain with a site in Belgium that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05387473Vrije Universiteit BrusselAdded Value of Cognitive Behavioural Therapy for Insomnia in Persons With Knee Osteoarthritis | 2026-12 |
| NCT07120646Vrije Universiteit BrusselPain and Sleep Disturbances in Children Living Beyond Cancer: A Case-Control Study | 2026-12 |
| NCT06970028Universitaire Ziekenhuizen KU LeuvenSomatosensory Phenotyping of ADPKD | 2026-12 |
| NCT06767930Université Catholique de LouvainEffects of HABIT-ILE in Adults with Bilateral Cerebral Palsy | 2026-12-31 |
| NCT06959056University Hospital, GasthuisbergEvaluating the Impact of Cryo-analgesia on Recovery After Double Lung Transplantation | 2026-12-31 |
Add all 9 to your calendar (.ics) → With an account.
Among the 150 studies in Pain with a site in Belgium, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study will examine how hybrid telerehabilitation is used in routine physiotherapy care for adults with anterior knee pain. Approximately 30 participants will be followed for 72 weeks while receiving individualized treatment from their physiotherapist, supported by the moveUP mobile application. The application provides prescribed exercises, educational information, communication with the physiotherapist, and progress monitoring.
The study will assess adherence to rehabilitation, pain, knee function, quality of life, psychological factors, and physical activity. It will also explore whether patient adherence and physiotherapist engagement are associated with clinical outcomes. Interviews with patients and healthcare professionals will examine barriers and facilitators to using the platform in routine care.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants receive individualized physiotherapy for anterior knee pain supported by the moveUP mobile application over 72 weeks. Treatment is prescribed and adapted by the treating physiotherapist according to individual patient needs.
Behavioral: Hybrid Telerehabilitation
Hybrid telerehabilitation combining routine physiotherapy with the moveUP mobile application for adults with anterior knee pain. The platform supports individualized exercise prescription, educational modules, patient-physiotherapist communication, and progress monitoring. Exercise selection, frequency, and progression are determined by the treating physiotherapist according to patient needs. Participants are followed for 72 weeks.
Exercise Adherence (ATEMPT Score)
Exercise adherence will be assessed using the Adherence to Exercise for Musculoskeletal Pain Tool (ATEMPT). Total scores range from 6 to 30, with higher scores indicating greater adherence.
Time frame: Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
Pain Intensity (Visual Analog Scale)
Pain intensity will be measured using a 0-100 mm Visual Analog Scale (VAS), where 0 indicates no pain and 100 indicates the worst pain imaginable. Higher scores indicate greater pain intensity.
Time frame: Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
Knee Function (Anterior Knee Pain Scale)
The Anterior Knee Pain Scale assesses symptoms and functional limitations associated with anterior knee pain. The total score ranges from 0 to 100, with higher scores indicating better function and fewer symptoms
Time frame: aseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
Health-Related Quality of Life (EQ-5D)
Health-related quality of life will be assessed using the EuroQol 5-Dimension 5-Level (EQ-5D-5L) questionnaire. Responses will be converted into a utility index using the Belgian value set. Scores range from -0.532 to 1, with higher scores indicating better health-related quality of life.
Time frame: Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
Fear of Movement (Tampa Scale for Kinesiophobia)
The 11-item Tampa Scale for Kinesiophobia assesses fear of movement or reinjury. The total score ranges from 11 to 44, with higher scores indicating greater kinesiophobia and therefore a worse outcome
Time frame: Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
Pain Catastrophizing (Pain Catastrophizing Scale)
The Pain Catastrophizing Scale is a 13-item questionnaire assessing catastrophic thoughts related to pain. The total score ranges from 0 to 52, with higher scores indicating greater pain catastrophizing and therefore a worse outcome
Time frame: Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
Physical Activity (Daily Step Count)
Time frame: Daily/weekly
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Sep 2026; primary completion for May 2028, 20 months later.
Of 3,734 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 20 months is above that.
Counting every sponsor, half of 3,833 studies reached it within 10 months; a quarter within 4 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.